Literature DB >> 18586933

Bias between the left and right inverted repeats during IS911 targeted insertion.

P Rousseau1, C Loot, C Turlan, S Nolivos, M Chandler.   

Abstract

IS911 is a bacterial insertion sequence composed of two consecutive overlapping open reading frames (ORFs [orfA and orfB]) encoding the transposase (OrfAB) as well as a regulatory protein (OrfA). These ORFs are bordered by terminal left and right inverted repeats (IRL and IRR, respectively) with several differences in nucleotide sequence. IS911 transposition is asymmetric: each end is cleaved on one strand to generate a free 3'-OH, which is then used as the nucleophile in attacking the opposite insertion sequence (IS) end to generate a free IS circle. This will be inserted into a new target site. We show here that the ends exhibit functional differences which, in vivo, may favor the use of one compared to the other during transposition. Electromobility shift assays showed that a truncated form of the transposase [OrfAB(1-149)] exhibits higher affinity for IRR than for IRL. While there was no detectable difference in IR activities during the early steps of transposition, IRR was more efficient during the final insertion steps. We show here that the differential activities between the two IRs correlate with the different affinities of OrfAB(1-149) for the IRs during assembly of the nucleoprotein complexes leading to transposition. We conclude that the two inverted repeats are not equivalent during IS911 transposition and that this asymmetry may intervene to determine the ordered assembly of the different protein-DNA complexes involved in the reaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18586933      PMCID: PMC2546779          DOI: 10.1128/JB.00452-08

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  34 in total

1.  IS911 transposition is regulated by protein-protein interactions via a leucine zipper motif.

Authors:  L Haren; C Normand; P Polard; R Alazard; M Chandler
Journal:  J Mol Biol       Date:  2000-02-25       Impact factor: 5.469

2.  Sub-terminal sequences modulating IS30 transposition in vivo and in vitro.

Authors:  Mónika Szabó; János Kiss; Zita Nagy; Michael Chandler; Ferenc Olasz
Journal:  J Mol Biol       Date:  2007-10-23       Impact factor: 5.469

3.  Control of IS911 target selection: how OrfA may ensure IS dispersion.

Authors:  Philippe Rousseau; Céline Loot; Catherine Guynet; Yoan Ah-Seng; Bao Ton-Hoang; Mick Chandler
Journal:  Mol Microbiol       Date:  2007-03       Impact factor: 3.501

4.  Transposition and target specificity of the typical IS30 family element IS1655 from Neisseria meningitidis.

Authors:  János Kiss; Zita Nagy; Gábor Tóth; György Botond Kiss; Júlia Jakab; Michael Chandler; Ferenc Olasz
Journal:  Mol Microbiol       Date:  2007-03       Impact factor: 3.501

5.  The global regulator H-NS binds to two distinct classes of sites within the Tn10 transpososome to promote transposition.

Authors:  Chris M Ward; Simon J Wardle; Randeep K Singh; David B Haniford
Journal:  Mol Microbiol       Date:  2007-05       Impact factor: 3.501

6.  An in vivo transposase-catalyzed single-stranded DNA circularization reaction.

Authors:  P Polard; M Chandler
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

7.  IS911-mediated transpositional recombination in vitro.

Authors:  P Polard; B Ton-Hoang; L Haren; M Bétermier; R Walczak; M Chandler
Journal:  J Mol Biol       Date:  1996-11-22       Impact factor: 5.469

8.  Factors affecting transposition activity of IS50 and Tn5 ends.

Authors:  K W Dodson; D E Berg
Journal:  Gene       Date:  1989       Impact factor: 3.688

9.  The nucleoid binding protein H-NS acts as an anti-channeling factor to favor intermolecular Tn10 transposition and dissemination.

Authors:  Randeep K Singh; Janine Liburd; Simon J Wardle; David B Haniford
Journal:  J Mol Biol       Date:  2007-12-23       Impact factor: 5.469

10.  The phage Mu transpososome core: DNA requirements for assembly and function.

Authors:  H Savilahti; P A Rice; K Mizuuchi
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  7 in total

1.  Characterization of the transposase encoded by IS256, the prototype of a major family of bacterial insertion sequence elements.

Authors:  Susanne Hennig; Wilma Ziebuhr
Journal:  J Bacteriol       Date:  2010-06-11       Impact factor: 3.490

2.  Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains.

Authors:  A Doléans-Jordheim; E Bergeron; F Bereyziat; S Ben-Larbi; O Dumitrescu; M-A Mazoyer; F Morfin; C Dumontet; J Freney; L P Jordheim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-15       Impact factor: 3.267

3.  Atypical integrative element with strand-biased circularization activity assists interspecies antimicrobial resistance gene transfer from Vibrio alfacsensis.

Authors:  Lisa Nonaka; Michiaki Masuda; Hirokazu Yano
Journal:  PLoS One       Date:  2022-08-02       Impact factor: 3.752

4.  A model for the molecular organisation of the IS911 transpososome.

Authors:  Philippe Rousseau; Catherine Tardin; Nathalie Tolou; Laurence Salomé; Mick Chandler
Journal:  Mob DNA       Date:  2010-06-16

Review 5.  Inner workings of RAG recombinase and its specialization for adaptive immunity.

Authors:  Xuemin Chen; Martin Gellert; Wei Yang
Journal:  Curr Opin Struct Biol       Date:  2021-07-07       Impact factor: 6.809

6.  The diversity of prokaryotic DDE transposases of the mutator superfamily, insertion specificity, and association with conjugation machineries.

Authors:  Romain Guérillot; Patricia Siguier; Edith Gourbeyre; Michael Chandler; Philippe Glaser
Journal:  Genome Biol Evol       Date:  2014-02       Impact factor: 3.416

7.  Structures of ISCth4 transpososomes reveal the role of asymmetry in copy-out/paste-in DNA transposition.

Authors:  Dalibor Kosek; Alison B Hickman; Rodolfo Ghirlando; Susu He; Fred Dyda
Journal:  EMBO J       Date:  2020-10-02       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.